GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » PB Ratio

Cytori Cell Research Institute (TSE:3750) PB Ratio : 4.32 (As of Jun. 08, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-08), Cytori Cell Research Institute's share price is 円1015.00. Cytori Cell Research Institute's Book Value per Share for the quarter that ended in Dec. 2023 was 円235.21. Hence, Cytori Cell Research Institute's PB Ratio of today is 4.32.

The historical rank and industry rank for Cytori Cell Research Institute's PB Ratio or its related term are showing as below:

TSE:3750' s PB Ratio Range Over the Past 10 Years
Min: 0.34   Med: 1.06   Max: 4.88
Current: 4.3

During the past 13 years, Cytori Cell Research Institute's highest PB Ratio was 4.88. The lowest was 0.34. And the median was 1.06.

TSE:3750's PB Ratio is ranked worse than
71.88% of 1305 companies
in the Biotechnology industry
Industry Median: 2.47 vs TSE:3750: 4.30

During the past 12 months, Cytori Cell Research Institute's average Book Value Per Share Growth Rate was -29.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -19.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -8.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -1.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cytori Cell Research Institute was 13.40% per year. The lowest was -28.10% per year. And the median was -3.90% per year.

Back to Basics: PB Ratio


Cytori Cell Research Institute PB Ratio Historical Data

The historical data trend for Cytori Cell Research Institute's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute PB Ratio Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 1.67 3.54 2.79 3.81

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 3.81 3.68 4.74 4.84

Competitive Comparison of Cytori Cell Research Institute's PB Ratio

For the Biotechnology subindustry, Cytori Cell Research Institute's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's PB Ratio falls into.



Cytori Cell Research Institute PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cytori Cell Research Institute's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1015.00/235.205
=4.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Cytori Cell Research Institute  (TSE:3750) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Cytori Cell Research Institute PB Ratio Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines